Business News Agency April 16th According to relevant sources from the National Development and Reform Commission, the National Development and Reform Commission is studying the principle of selection of uniform pricing varieties, striving to determine the first batch of uniform price varieties this year.
Recently, the news that the Price Division of the National Development and Reform Commission formulated a national uniform price for some varieties of essential medicines has attracted the attention of the industry.
In recent years, the phenomenon of tendering only for essential medicines in some localities has also existed. Too low prices make some varieties that have already been tendered for many times, with little room for price contraction but which are clinically necessary. Even if they win the bid, companies will abandon production and supply. The National Development and Reform Commission formulated a unified price for some “multiple tenders, adequate supply, and stable prices†so that this part of the bidding for basic drugs can become a “quality†to ensure the supply of clinical drugs.
A reporter from the “Pharmaceutical Economics News†learned that the so-called uniform price of basic drugs does not mean a unified retail guide price. Since the basic drugs are zero-sales sales, the unified price is both the tender price and the sales price. A reasonable tender price is conducive to ensuring the safety of medicines and thus relieves the public of drug risks. In the opinion of many people in the industry, through the establishment of a unified tender price, this part of the bidding difficulties for cheap essential medicines will gradually be resolved.
This year, we will strive to determine the first batch of uniform prices.
In the tendering process for essential medicines, how to achieve the best quality with the lowest price has always been a difficult problem.
In order to solve the quality problem, Yu Mingde, the president of the Chinese Pharmaceutical Enterprises Management Association, once proposed that “the price of the floor of medicines should be establishedâ€, that is, the lowest price that can guarantee the quality, so as to ensure the quality of medicines. In contrast, the formulation of a unified price goes further than the floor price, and it is more likely to completely break through the vicious circle of "only low is to take".
Zhou Yan, secretary-general of the China Chemical Pharmaceutical Industry Association, said: "At the beginning of the basic drug system design, industry associations had suggested that basic drugs should not raise prices, but it was difficult to be recognized. This time, the National Development and Reform Commission plans to formulate a unified price for some essential drugs, indicating that the country is System design began to take a deeper level of consideration."
According to relevant persons from the National Development and Reform Commission, "Price management of essential medicines must be developed in this direction. At present, the National Development and Reform Commission is studying the principle of selection of uniform pricing varieties, and is soliciting opinions to strive to determine the first batch of uniform price varieties this year."
Basic medicines are all cheap products, and there is limited space for price cuts. For many companies, too low prices can hardly guarantee quality. Zhou Yan pointed out: "Some companies bid at a low price, but they can not guarantee the supply of the bid. Therefore, based on the unified price, the competition should be quality and service."
"As long as the uniform price is not lower than the 'critical price', enterprises can accept it." Yang Changshun, general manager of Jiangxi Sanjing Yian Pharmaceutical Co., Ltd., said: "The so-called 'critical price' means that when a drug is low in price, it can also be used as a drug company. Maintaining the same fashion as the current promotion team has a small advantage, the quality of medicines has not yet declined, and it is still possible to cure the disease. We can think that such a price is the 'critical price' for its survival."
The Preliminary Assumption of Meeting the Conformity Pricing Conditions
Speaking of the effect of unified pricing on bidding, Song Dacai, Director of Pharmaceutical Price Division of the Price Division of the National Development and Reform Commission, believes: “By formulating a unified price, we can avoid potential quality risks. In the bidding process, we will only recruit quality and service, and we will not raise prices. â€
According to the reporter's understanding, the Anhui model, known as the "National Bidding Sample," used the double-envelope system in the bidding for Indian medicines. However, in actual operation, most companies do not have problems in the envelope of "quality and service". The "price" envelope has become the key to the success or failure of tendering.
No longer "only low price is the take" is the change brought about by the uniform tender price, but the purpose of the tender is to choose the best price product from the qualified candidates. In view of some companies, double envelopes still have the necessary reserve. .
A person from a central government thinks: “The fundamental problem in tendering is to make good use of medical insurance funds. At present, under the double-envelope model tendering, enterprises rarely get stuck in quality. If they do not raise prices, it will be difficult to determine who will win the tender. Lost the significance of the tender."
On this issue, Zhou Yan pointed out: "Unified pricing also has an objective relationship between quantity and price. Therefore, the determination of the pricing basis is critical, and it will be difficult to avoid volume and price negotiations in the future."
In the absence of price hikes, the Development and Reform Commission has also tentatively envisaged how this group of drug-based products compete with quality and service. According to a person familiar with the matter, “The basic drug bidding companies that participated in the unified pricing also put forward some requirements. For example, the enterprises participating in the bidding are ranked high and the market share is over 80%. By increasing the degree of concentration, they can achieve large-scale and intensive production. Ensure supply and quality."
"The supply of essential drugs is the original intention of the design of the basic drug system," said Zhou Yan. "The state advocates enterprises to improve their ability to innovate, adjust their structure, and become bigger and stronger. If the tender is only low-cost, it will be the industry in the long run. If the direction of development is opposite, it will not be able to play the role of positive elimination of tenders. Only by focusing on quality and service can we highlight the advantages of large enterprises and featured enterprises, and not only guarantee the establishment and implementation of basic drug systems, but also conform to the direction of enterprise development advocated by the state. It is also a true and responsible attitude towards the health of the people."
Recently, the news that the Price Division of the National Development and Reform Commission formulated a national uniform price for some varieties of essential medicines has attracted the attention of the industry.
In recent years, the phenomenon of tendering only for essential medicines in some localities has also existed. Too low prices make some varieties that have already been tendered for many times, with little room for price contraction but which are clinically necessary. Even if they win the bid, companies will abandon production and supply. The National Development and Reform Commission formulated a unified price for some “multiple tenders, adequate supply, and stable prices†so that this part of the bidding for basic drugs can become a “quality†to ensure the supply of clinical drugs.
A reporter from the “Pharmaceutical Economics News†learned that the so-called uniform price of basic drugs does not mean a unified retail guide price. Since the basic drugs are zero-sales sales, the unified price is both the tender price and the sales price. A reasonable tender price is conducive to ensuring the safety of medicines and thus relieves the public of drug risks. In the opinion of many people in the industry, through the establishment of a unified tender price, this part of the bidding difficulties for cheap essential medicines will gradually be resolved.
This year, we will strive to determine the first batch of uniform prices.
In the tendering process for essential medicines, how to achieve the best quality with the lowest price has always been a difficult problem.
In order to solve the quality problem, Yu Mingde, the president of the Chinese Pharmaceutical Enterprises Management Association, once proposed that “the price of the floor of medicines should be establishedâ€, that is, the lowest price that can guarantee the quality, so as to ensure the quality of medicines. In contrast, the formulation of a unified price goes further than the floor price, and it is more likely to completely break through the vicious circle of "only low is to take".
Zhou Yan, secretary-general of the China Chemical Pharmaceutical Industry Association, said: "At the beginning of the basic drug system design, industry associations had suggested that basic drugs should not raise prices, but it was difficult to be recognized. This time, the National Development and Reform Commission plans to formulate a unified price for some essential drugs, indicating that the country is System design began to take a deeper level of consideration."
According to relevant persons from the National Development and Reform Commission, "Price management of essential medicines must be developed in this direction. At present, the National Development and Reform Commission is studying the principle of selection of uniform pricing varieties, and is soliciting opinions to strive to determine the first batch of uniform price varieties this year."
Basic medicines are all cheap products, and there is limited space for price cuts. For many companies, too low prices can hardly guarantee quality. Zhou Yan pointed out: "Some companies bid at a low price, but they can not guarantee the supply of the bid. Therefore, based on the unified price, the competition should be quality and service."
"As long as the uniform price is not lower than the 'critical price', enterprises can accept it." Yang Changshun, general manager of Jiangxi Sanjing Yian Pharmaceutical Co., Ltd., said: "The so-called 'critical price' means that when a drug is low in price, it can also be used as a drug company. Maintaining the same fashion as the current promotion team has a small advantage, the quality of medicines has not yet declined, and it is still possible to cure the disease. We can think that such a price is the 'critical price' for its survival."
The Preliminary Assumption of Meeting the Conformity Pricing Conditions
Speaking of the effect of unified pricing on bidding, Song Dacai, Director of Pharmaceutical Price Division of the Price Division of the National Development and Reform Commission, believes: “By formulating a unified price, we can avoid potential quality risks. In the bidding process, we will only recruit quality and service, and we will not raise prices. â€
According to the reporter's understanding, the Anhui model, known as the "National Bidding Sample," used the double-envelope system in the bidding for Indian medicines. However, in actual operation, most companies do not have problems in the envelope of "quality and service". The "price" envelope has become the key to the success or failure of tendering.
No longer "only low price is the take" is the change brought about by the uniform tender price, but the purpose of the tender is to choose the best price product from the qualified candidates. In view of some companies, double envelopes still have the necessary reserve. .
A person from a central government thinks: “The fundamental problem in tendering is to make good use of medical insurance funds. At present, under the double-envelope model tendering, enterprises rarely get stuck in quality. If they do not raise prices, it will be difficult to determine who will win the tender. Lost the significance of the tender."
On this issue, Zhou Yan pointed out: "Unified pricing also has an objective relationship between quantity and price. Therefore, the determination of the pricing basis is critical, and it will be difficult to avoid volume and price negotiations in the future."
In the absence of price hikes, the Development and Reform Commission has also tentatively envisaged how this group of drug-based products compete with quality and service. According to a person familiar with the matter, “The basic drug bidding companies that participated in the unified pricing also put forward some requirements. For example, the enterprises participating in the bidding are ranked high and the market share is over 80%. By increasing the degree of concentration, they can achieve large-scale and intensive production. Ensure supply and quality."
"The supply of essential drugs is the original intention of the design of the basic drug system," said Zhou Yan. "The state advocates enterprises to improve their ability to innovate, adjust their structure, and become bigger and stronger. If the tender is only low-cost, it will be the industry in the long run. If the direction of development is opposite, it will not be able to play the role of positive elimination of tenders. Only by focusing on quality and service can we highlight the advantages of large enterprises and featured enterprises, and not only guarantee the establishment and implementation of basic drug systems, but also conform to the direction of enterprise development advocated by the state. It is also a true and responsible attitude towards the health of the people."
1. We have Good location
We`re located in the well known Ningbo International Port.
2. We`re Well-experienced
Tropical Group has many factories in the world, has 48 years experience in seafood export
3. We`re High quality assurance
Our company has passed HACCP, BRC, MSC, FDA, KOSHER and the other certifications.
4. We can do Best price
We are an industry and trade integration enterprise, which producing, packing and selling all by ourselves, greatly reducing the price difference caused by broker
5. We have Rich products
We have our own design department and R & D team, which can design personalized products according to customers' requirements.
6. We can do On-time delivery
Our products are exported to the United States, South America, Africa, Europe, Russia and other countries and regions. Company exports amounted to more than US$60 million in last year, enjoys high reputation in the aquatic products industry.
Contact: Ms. Sunny Wang
Fish Canned,Saury In Oil,Canned Saury In Oil,Saury In Vegetable Oil
Tropical Food Manufacturing (Ningbo) Co., Ltd. , https://www.tropical-food.com